Philips Announces Breakthrough in New Medical Imaging Technology

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the first 3D imaging results obtained with a new imaging technology called Magnetic Particle Imaging (MPI). The technology, which uses the magnetic properties of iron-oxide nanoparticles injected into the bloodstream, has been used in a pre-clinical study to generate unprecedented real-time images of arterial blood flow and volumetric heart motion. This represents a major step forward in taking Magnetic Particle Imaging from a theoretical concept to an imaging tool to help improve diagnosis and therapy planning for many of the world’s major diseases, such as heart disease, stroke and cancer. The results of the pre-clinical study were published in issue 54 of Physics in Medicine and Biology (2009).

"A novel non-invasive cardiac imaging technology is required to further unravel and characterize the disease processes associated with atherosclerosis, in particular those associated with vulnerable plaque formation which is a major risk factor for stroke and heart attacks," says Professor Valentin Fuster, M.D., Ph.D., director of the Mount Sinai Heart Center, New York. "Through its combined speed, resolution and sensitivity, Magnetic Particle Imaging technology has great potential for this application, and the latest in-vivo imaging results represent a major breakthrough."

"We are the first in the world to demonstrate that Magnetic Particle Imaging can be used to produce real-time in-vivo images that accurately capture cardiovascular activity," says Henk van Houten, senior vice president of Philips Research and head of the Healthcare research program. "By adding important functional information to the anatomical data obtained from existing modalities such as CT and MR, Philips' MPI technology has the potential to significantly help in the diagnosis and treatment planning of major diseases such as atherosclerosis and congenital heart defects."

Philips' Magnetic Particle Imaging uses the magnetic properties of injected iron-oxide nanoparticles to measure the nanoparticle concentration in the blood. Because the human body contains no naturally occurring magnetic materials visible to MPI, there is no background signal. After injection, the nanoparticles therefore appear as bright signals in the images, from which nanoparticle concentrations can be calculated. By combining high spatial resolution with short image acquisition times (as short as 1/50th of a second), Magnetic Particle Imaging can capture dynamic concentration changes as the nanoparticles are swept along by the blood stream. This could ultimately allow MPI scanners to perform a wide range of functional cardiovascular measurements in a single scan. These could include measurements of coronary blood supply, myocardial perfusion, and the heart's ejection fraction, wall motion and flow speeds.

The results obtained from Philips' experimental MPI scanner mark an important step towards the development of a whole-body system for use on humans. Some of the technical challenges in scaling up the system relate to the magnetic field generation required for human applications. Others lie in the measurement and processing of the extremely weak signal emitted by the nanoparticles. Signal measurement and processing are areas where Philips has a great deal of proven expertise and experience that it is currently applying to the task.

The scientific article "Three-dimensional real-time in vivo magnetic particle imaging" published in issue 54 of Physics in Medicine and Biology (2009) can be downloaded from http://stacks.iop.org/0031-9155/54/L1.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 121,000 employees in more than 60 countries worldwide. With sales of EUR 26 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

AI Helps Physicians Better Assess the Ef…

In a small but multi-institutional study, an artificial intelligence (AI)-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder...

Smartwatches and Fitness Bands Reveal In…

A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the...

AI may Detect Earliest Signs of Pancreat…

An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed...

Open Call U4H-2022-PJ2: Call for Proposa…

The Ukraine crisis has an unprecedented impact on the mental health of the displaced people in the EU coming from Ukraine. The conflict and experiences of people in war zones...

AI Reduces Miss Rate of Precancerous Pol…

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reported a team of international researchers led by Mayo Clinic. The study is...

Medical Valley EMN & Volitan Global …

The two healthcare innovation experts Medical Valley EMN and Volitan Global strengthen their existing inbound- and outbound activities through a strategic partnership. The aim is to offer companies access to...

DMEA - Connecting Digital Health Opens w…

26 - 28 April 2022, Berlin, Germany. What plans does the new federal government have concerning the digital transformation of the healthcare sector? What are the initial experiences of doctors regarding...

AI can Predict Probability of COVID-19 v…

Testing shortages, long waits for results, and an over-taxed health care system have made headlines throughout the COVID-19 pandemic. These issues can be further exacerbated in small or rural communities...

Using AI to Detect Cancer from Patient D…

A new way of using artificial intelligence to predict cancer from patient data without putting personal information at risk has been developed by a team including University of Leeds medical...

Oulu University Hospital Expands Partner…

Siemens Healthineers and Oulu University Hospital in Finland have entered a strategic partnership for the next ten years, adding to an existing radiotherapy collaboration to jointly expand and modernize the...

Positive Conclusion to DMEA - Connecting…

26 - 28 April 2022, Berlin, Germany. After three days DMEA, Europe's leading digital health event, came to a successful conclusion - with around 11,000 visitors, more than 500 exhibitors and...

AI-Enabled ECGs may Identify Patients at…

Atrial fibrillation, the most common cardiac rhythm abnormality, has been linked to one-third of ischemic strokes, the most common type of stroke. But atrial fibrillation is underdiagnosed, partly because many...